Decreased CDH1 expression is positively correlated with gastric cancer progression [25–27]; the decreased CDH1 (E-Cadherin) expression observed here might partially explain the ability of UBE2T knockdown to attenuate gastric tumor formation and growth. Here, UBE2T is linked to gastric cancer.